The head of the health department Marek Krajčí has allowed the largest import of medicines with the active substance Ivermectin so far. A part of tens of thousands of packages should come to Slovakia next week.
Which medicines are:
Ivermectin Tablet USP IverJohn-6 tbl. 100x6 mgOn 19 February 2021, the Ministry of Health authorised the therapeutic use of the unregistered medicine Ivermectin Tablet USP IverJohn-6 tbl. 100x6 mg with indication prevention and treatment of COVID-19 disease per 20,000 units.
Ivermex tbl. 4x3 mgOn 19 February 2021, the Ministry of Health authorised the therapeutic use of the unregistered product Ivermex tbl. 4x3 mg with indication prevention and treatment of COVID-19 for 30,000 units. 8,930 packages could be imported in Slovakia next week.
Ermetin tbl.On 19 February 2021, the Ministry of Health authorised the therapeutic use of the unregistered product Ermetin tbl. 10x3 mg with the indication prevention and treatment of COVID-19 for 30,000 units. The manufacturer has sent an order for 30,000 items available and ready for dispatch. They could be available in Slovakia next week (9th week).
The Minister of Health, Marek Krajčí, has already approved supplies of ivermectin for hospitals and the first few thousand packages for pharmacies in recent weeks. The supply comes gradually, it is on the distributor how quickly he can deliver it, which the Ministry of Health cannot influence. At the same time, the fact is that demand for these medicines is global. In Slovakia, we respond quickly on the basis of the recommendations of the main experts for individual medical areas, since not only the effectiveness, but also patient safety is the first priority for us, Minister Krajčí explained.
Experts at the Ministry are following the situation.
Colchicum-Dispert, tbl obd 20x0.5 mgOn 2 February 2021, the Ministry of Health authorised the therapeutic use of Colchicum-Dispert, tbl obd 20x0.5 mg for the early treatment of COVID-19. Colchicum-Dispert, tbl obd 20x0.5 mg in the number of 10,000 pieces was imported to distribution companies on February 18, 2021 and is available for pharmacies.
Ivermectin Tablet USP IverJohn-6 tbl. 100x6 mg and Ivert 6 tbl 4x1x6 mgOn 8 February 2021, the Ministry of Health authorised the therapeutic use of the unregistered product Ivermectin Tablet USP IverJohn-6 tbl. 100x6 mg and Ivert 6 tbl 4x1x6 mg with the main indication prevention and treatment of COVID-19. On 19.2.2021 2,000 pieces Ivermectin Tablet USP IverJohn-6 tbl. 100x6 mg and 7,000 pieces Ivert 6 tbl 4x1x6 mg were imported into the EN.
Ivert 6 tbl 4x1x6 mg will be transported to distribution depots and on Tuesday or Wednesday it should be distributed by all large distributors to public pharmacies throughout Slovakia. Ivermectin Tablet USP IverJohn-6 tbl. 100x6 mg was distributed to hospital pharmacies today - on Monday 22.2.2021.
Isoprinosine tabl.Isoprinosine tabl. 100 x 500 mg and 50 x 500 mg were imported to Slovakia on Monday 22 February 2021 in the number of 21 468 pieces of Isoprinosine tabl. 100 x 500 mga 21 300 pieces Isoprinosine tabl. 50 x 500 mg (originally 5,000 pieces). This is an increase from the original quantity in the total number of almost 42 768 pieces. Isoprinosine 1000 mg granules for oral solution and also Isoprinosine syrup are also available.
Dexamethasone inj. Biodexone 10x5x2 mlOn 4 February 2021, the Ministry of Health authorised the therapeutic use of Dexamethhasone inj. Biodexone 10x5x2 ml. On 12.2.2021 1000 pieces of Dexamethasone inj were transferred to hospitals. Biodexone 10x5x2 ml. A further 1,000 were imported today, Monday 22.2.2021. Another 1,000 will be delivered next week.
InomedINOMED 500 mg tbl (blis. PVC/PVDC/Alu) 1x100 pieces were imported on February 8, 2021 in the number of 12,000 pieces into the construction warehouse and subsequently distributed from 9.2.2021 to individual distribution companies. The nearest imports of INOMED are expected in the 3rd decade of April 2021 in the number of 8,000 pieces INOMED 500 mg tbl 1x50 and 12,000 pcs INOMED 500 mg tbl 1x100 pcs.
FabifluOn 17 December 2020, the Ministry of Health authorised the therapeutic use of unregistered Fabiflu tbl flm 34x200 mg in the indication suspected or confirmed COVID-19 infection. To date 22.2.2021 less than 5,000 were transported to hospitals, 6,000 still available. With regard to further possible deliveries, the producer can provide additional quantities within approximately 10 working days.